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Abstract
Simple synthetic routes are given to the Ag(I) complexes, [Ag2(imH)4](salH)2 (imH = imidazole; salH2 = salicylic acid), [Ag(Me-
NO2imH)2]ClO4 Æ nH2O (MeNO2imH = 2-methyl-5-nitroimidazole; n = 1, 3), [Ag(NO2im)] (NO2imH = 5-nitroimidazole) and [Ag-
(apim)]ClO4 (apim = 1-(3-aminopropyl)imidazole). X-ray crystal structures of [Ag2(imH)4](salH)2, [Ag(MeNO2imH)2]ClO4 Æ H2O and
[Ag(apim)]ClO4 were obtained. The new Ag(I) complexes and related known Ag(I) imidazolates were screened for their growth inhib-
itory effects (in vitro) against the pathogenic bacteria methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli and also
the fungal pathogen Candida albicans. [Ag2(imH)4](salH)2, in comparison to the prescription drug silver sulfadiazine, had significantly
better anti-bacterial qualities, whilst against the fungus C. albicans it was 47 times more potent than the marketed drug ketoconazole.
 2005 Elsevier Ltd. All rights reserved.
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1. Introduction
With the ever-increasing problem of microbe resistance
to current antimicrobial drugs, particularly antibiotics,
there is an urgent demand for new classes of compounds
that will efficiently inhibit the growth of pathogenic micro-
organisms. Silver and its simple salts have been known for
centuries to exert anti-infective properties. However, the
use of silver metal and its salts as antimicrobial agents
declined sharply towards the middle of the last century
upon the introduction of antibiotics. Amongst the few
silver(I) compounds commonly prescribed today for their
topical anti-bacterial effects are silver sulfadiazine (Silvad-
ene, Flamazine) for the treatment of burns, and a dilute
solution of AgNO3, which is used for the prophylaxis of
infectious bacterial conjunctivitis in infants [1,2]. Ag(I)-
impreganted carboxymethylcellulose, marketed as Aquacel
Ag, is a hydrofibre dressing with acclaimed antimicrobial
properties and is prescribed for use on various categories
of open wounds [3]. Along similar lines, Youngs et al. [4]
recently reported the preparation of nano-fibre mats encap-
sulating an Ag(I)-imidazole cyclophane gem-diol complex
and demonstrated the impressive bactericidal and fungi-
cidal properties of the material. Biocide additives based
on Ag(I) ions have been shown to exhibit an antimicrobial
effect in various powder paint coating systems and are
thought to have potential use in areas necessitating a sterile
environment or where strict hygiene standards are required
[5]. Silver sols (i.e., electrochemically generated colloidal
suspensions of metallic silver in water) have also found
application as bactericidal agents [6], although it has been
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recently reported [7] that such potency claims are mislead-
ing. The active agent is Ag+, with bacterial metabolism
being disrupted by its presence.
As part of our ongoing efforts into the development of
new metal-based antimicrobial complexes [8–11] we have
revisited the general area of silver-containing agents.
Recently, a selection of mono- [12] and bi-nuclear [13]
Ag(I) complexes, incorporating substituted imidazole
ligands, were prepared and these displayed moderate activ-
ity against the human fungal pathogen Candida albicans.
Imidazoles were selected as the coordinating ligands as
these N-heterocycles bear a close relationship with natu-
rally occurring biomolecules incorporating histidine resi-
dues. Although simple Ag(I) salts, such as AgNO3 and
AgClO4, exhibit good anti-Candida activity (minimum
inhibitory concentration (MIC) 30 and 44 lM, respec-
tively, in RPMI media) this is surpassed by the salicylate
complex [Ag2(salH)2] (salH2 = salicylic acid) (MIC = 5 lM
in RPMI media) [14]. A further 10-fold enhancement in
bioactivity was found for the ammonia-containing silver
salicylate complex [Ag2(NH3)2(salH)2] (MIC = 0.5 lM in
RPMI media). Attempts to improve the antifungal activity
by co-ligating salicylate with imidazole (imH = imidazole)
at an Ag(I) centre forms the basis of the present work.
Herein, is described the preparations of the Ag(I)
complexes [Ag2(imH)4](salH)2, [Ag(MeNO2imH)2]ClO4 Æ
nH2O (MeNO2imH = 2-methyl-5-nitroimidazole; n = 1, 3),
[Ag (NO2im)] (NO2imH = 5-nitroimidazole) and [Ag-
(apim)]ClO4 (apim = 1-(3-aminopropyl)imidazole). Ligand
structures are shown in Fig. 1. X-ray crystal structures of
[Ag2(imH)4](salH)2, [Ag(MeNO2imH)2]ClO4 Æ H2O and
[Ag(apim)]ClO4 were obtained.
The new Ag(I) complexes, in addition to previously
known and related Ag(I) imidazolates, were screened for
their growth inhibitory effects (in vitro) against the follow-
ing opportunistic human microbial pathogens: the Gram
positive coccus bacterium methicillin-resistant Staphylococ-
cus aureus (MRSA), the Gram negative bacillus bacterium
Escherichia coli and the fungus C. albicans.
2. Results and discussion
The imidazole/salicylate complex [Ag2(imH)4](salH)2
forms in moderate yield by reacting [Ag2(salH)4] with imid-
azole in an approximate 1:4 molar ratio (Scheme 1). The
complex was characterised by X-ray crystallography
(Fig. 2 and Table 1) and comprises a H-bonded supramo-
lecular assembly. Two neutral imH ligands are bonded to
the metal via their imine N atoms (mean Ag–N =
2.0951(15) A˚) in an almost linear fashion (N3–Ag1–
N1 = 178.82(6)). There is a very weak Ag–Ag interaction
(Ag  Ag = 3.7178(4) A˚) but the more important contribu-
tions to holding the assembly together are the H-bonds
involving the carboxylate oxygens of the salH ligands
and the H atom on the imidazole amine N atom. There
are also p–p interactions between the imidazole rings
(inclined at 16 to each other and, on average, the vertical
distance between the rings is ca. 3.4 A˚) and a further long
interaction (2.9702(14) A˚) between the Ag(I) centre and
an adjacent phenolic oxygen atom (Fig. 3). The structure
of [Ag2(imH)4](salH)2 differs markedly from that of
[Ag2(NH3)2(salH)2] [14], where each metal is coordinated
directly to a salicylate carboxylate oxygen (Ag–O =
2.1699(14) A˚) and to an ammonia nitrogen atom (Ag–
N = 2.1367(17) A˚), and also in a slightly less linear manner
{O3–Ag–N1 = 175.37(5)}. In addition, the Ag–Ag dis-
tance in [Ag2(NH3)2(salH)2] (3.0685(4) A˚) is significantly
shorter than in [Ag2(imH)4](salH)2. Gold and Gregor [15]
calculated the formation constants (in aqueous 1.0 M
KNO3) for [Ag(imH)]
+ (logK1 = 3.11) and [Ag(imH)2]
+
(logK2 = 3.73) to be very similar to those for [Ag(NH3)]
+
and [Ag(NH3)2]
+ (logK1 = 3.24, logK2 = 3.81).
A brief comment on the synthesis and structures of
other related Ag(I) complexes containing non-functional-
ised imidazole ligands is warranted. The imidazole complex
salt [Ag(imH)2]NO3 has been prepared by reacting AgNO3
with imH (ca. 1:4 molar ratio) [16] and in the [Ag(imH)2]
+
cation the metal is bonded to the imine N atoms of two
neutral imidazole ligands [17] and in a similar fashion to
that found in the core structure of [Ag2(imH)4](salH)2. In
[Ag(imH)2]
+ the two Ag–N bonds lie 5.7 and 3.2 out of
the imidazole planes, respectively, and the dihedral angle
between the imidazole groups is 20.2. [Ag(imH)2]NO3
forms at pH 4, suggesting that Ag(I) ions compete
against protons for imidazole groups more successfully
than for amino groups. Amines are, in fact, much stronger
bases than imidazole towards protons [17]. The imidazolate
complex, [Ag(im)], containing a deprotonated imidazole
(im) ligand, has been prepared in a similar manner to
[Ag(imH)2]NO3, but with the inclusion of NaOH in the
N
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Fig. 1. Ligand structures and abbreviations.
[Ag (apim)]ClO4[Ag (MeNO2imH)2]C lO4.nH2O MeNO2imH apimAgClO4.H2O
[Ag2(imH)4]( salH)2 [Ag (NO2im)]
NO2imHimH [Ag2 (salH)2]
Scheme 1.
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reaction mixture [16,18]. Ionisation of imH to im changes
the monodentate imH lig into the bifunctional im ligand
and X-ray powder diffraction studies [18] have revealed
the polymeric nature of [Ag(im)] (mean Ag–N 2.08 A˚) with
linearly coordinated N–Ag–N ligands (171.8(8) and
167.6(1)) and short interchain Ag  Ag contacts
(3.161(4) A˚). Hexameric [Ag6(imH)12](ClO4)6 forms from
AgClO4 and imH in water containing added perchloric acid
[19] and the large cation comprises a planar (Ag+)6 cluster,
in which three radiating pairs of Ag+ ions (3.051(1) A˚
apart) are on the corners of an equilateral triangle, the
inner Ag+ ions being 3.493(1) A˚ apart. Each metal ion car-
ries two, linearly coordinated, neutral imidazole ligands
and two distinct Ag–N bonding distances are evident
(Ag(1)–N(1) 2.075(3) A˚; Ag(2)–N(3) 2.089(3) A˚).
Reaction of MeNO2imH with AgClO4 in a 2:1 molar
ratio gives [Ag(MeNO2imH)2]ClO4 Æ 3H2O in good yield
(Scheme 1). Initial attempts to form an Ag(I) complex of
MeNO2imH by reaction with AgClO4 in a 4:1 molar ratio
led to the co-crystallisation of metal-free MeNO2imH with
[Ag(MeNO2imH)2]ClO4 Æ H2O. This Ag(I) monohydrate
complex was crystallographically characterised (Fig. 4
and Table 2) (orthorhombic, Pnma). The metal ion lies
on a centre of symmetry and the perchlorate anion rests
on a mirror plane, such that the asymmetric unit comprises
half of the cation, half the anion and one water molecule.
The metal ion is bonded to the imine N atoms (adjacent
to the nitro group) of two diagonally opposed MeNO2imH
ligands (Ag–N = 2.126(0) A˚; N–Ag–N = 180). There are
also long intramolecular contacts between one nitro O
Fig. 2. Structure of [Ag2(imH)4](salH)2.
Table 1
Selected bond lengths (A˚) and angles () for [Ag2(imH)4](salH)2
Ag(1)–N(3) 2.0934(15)
Ag(1)–N(1) 2.0967(15)
Ag(1)–O(1)#1 2.9702(14)
Ag(1)–Ag(1)#2 3.7178(4)
N(3)–Ag(1)–N(1) 178.82(6)
N(3)–Ag(1)–O(1)#1 98.67(5)
N(1)–Ag(1)–O(1)#1 81.63(5)
N(3)–Ag(1)–Ag(1)#2 96.90(4)
N(1)–Ag(1)–Ag(1)#2 82.09(4)
O(1)#1–Ag(1)–Ag(1)#2 133.03(3)
Symmetry transformations used to generate equivalent atoms: #1 x, y,
z  1; #2 x + 1, y, z + 1.
Fig. 3. Interaction between the Ag(I) centre and an adjacent phenolic
oxygen atom in the structure of [Ag2(imH)4](salH)2.
Fig. 4. Structure of [Ag(MeNO2imH)2]ClO4 Æ H2O.
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atom on each MeNO2imH ligand and the metal (Ag1–
O1 = 2.9236(17) A˚; O1A–Ag–O1 = 180). The [Ag(Me-
NO2imH)2]
+ cations are linked into two-dimensional
sheets via shorter ONO–Ag–ONO axial interactions
(Ag1–O2#1 = 2.8735(17) A˚) (Fig. 5) and these, in turn,
are linked by hydrogen-bonding through the water solvate,
to intervening layers containing the perchlorate anion and
water molecule. As a consequence of the inter- and intra-
molecular ONO–Ag interactions the nitrate N–O distances
in [Ag(MeNO2imH)2]ClO4 Æ H2O are marginally longer
than in metal-free MeNO2imH [20].
The related, non-methylated imidazole, 5-nitroimidazole
(NO2imH), is known to react with AgNO3 and AgBF4 in
strongly acidic solution to form the salts [Ag(NO2imH)2]X
(X = NO3, BF4) [21]. Both salts have been crystallographi-
cally characterised ([Ag(NO2imH)2]NO3, monoclinic, P2/n;
[Ag(NO2imH)2]BF4, monoclinic, P21/c), and in each case
the metal is coordinated to the endocyclic N atom adjacent
to the nitro group (mean N–Ag–N = 166.1 for nitrate salt
and 175.2 for tetrafluoroborate salt). One O atom of each
nitro group makes a secondary Ag–O bond near the equa-
torial plane. The anions are hydrogen bonded to the ligand
NH groups. Whilst the mean Ag–N and Ag–O bonding dis-
tances in [Ag(NO2imH)2]X and [Ag(MeNO2imH)2]ClO4 Æ
H2O are quite similar substantial differences are apparent
in the N–Ag–N, O–Ag–O and N–Ag–O bond angles. Solu-
tion 1H and 13C NMR spectra of the [Ag(NO2imH)2]X salts
showed that the cationic complexes dissociate in DMSO
[21].
It was also reported [21] that in neutral or weakly acidic
aqueous media NO2imH reacts with AgNO3 and AgBF4 to
give the insoluble NO2im
 complex, [Ag(NO2im)], whose
IR and 13C NMR spectra were consistent with a polymeric
chain of deprotonated ligands bridging Ag(I) centres via
the ring N atoms. In the present work the related complex,
[Ag(MeNO2im)], is obtained upon addition of MeNO2imH
to [Ag2(salH)4] in a 3:1 molar ratio (Scheme 1), suggesting
that deprotonation of MeNO2imH is a consequence of the
basicity of the salH ion (pKa of salH2 = 3.4).
The white solid, [Ag(apim)]ClO4, forms in good yield
upon treating AgClO4 with apim in ethanol (Scheme 1).
The insolubility of the complex (in ethanol and water) sug-
gested a polymeric structure involving the primary amine
group and the ring imine N atom. This was confirmed by
X-ray crystallographic studies (Figs. 6 and 7; Table 3) which
revealed a wavy polymeric chain containing two-coordinate
Ag(I) ions with additional weaker metal-perchlorate Ag–
ClO4–Ag intrastrand interactions. Each perchlorate also
makes two further interstrand H-bonds to amine protons
(not shown in figures). Furthermore, there are interstrand
crosslinks arising from weak Ag–N(imine) interactions
(Fig. 7). There are also very weak interactions between per-
chlorate ions and imine nitrogens (not shown in figures) but
there are no indications of any significant Ag–Ag bonding.
Microbial growth inhibition data are given in Table 4.
The metal-free organic ligands were essentially inactive
against all of the test microbes. All of the tabulated sil-
ver-containing species exhibited significantly greater anti-
fungal than anti-bacterial activity. [Ag2(imH)4](salH)2
was, universally, the most active complex. The complex,
in comparison to the prescription drug silver sulfadiazine,
had significantly better anti-bacterial qualities, whilst
against the fungus C. albicans it was 47 times more potent
than the marketed drug ketoconazole. Surprisingly, the
hexanuclear imidazole complex, [Ag6(imH)12](ClO4)6, was
ineffective against both bacterial species but was highly
toxic towards C. albicans, indicating some degree of selec-
tivity between anti-bacterial and anti-fungal activity. In a
similar fashion, the simple Ag(I) salts, AgNO3 and
AgClO4 Æ H2O, and the nitroimidazolate complex,
[Ag(NO2im)], were only marginally active against bacteria
Fig. 5. Linking of [Ag(MeNO2imH)2]
+ cations into two-dimensional
sheets via long Ag–ONO interactions.
Table 2
Selected bond lengths (A˚) and angles () for [Ag(MeNO2imH)2]ClO4 Æ H2O
Ag(1)–N(1) 2.1260(16)
Ag(1)–O(2)#1 2.8735(17)
Ag(1)–O(1) 2.9236(17)
N(3)–O(1) 1.231(2)
N(3)–O(2) 1.234(2)
N(1)#2–Ag(1)–N(1) 180.0
N(1)#2–Ag(1)–O(2)#1 94.29(5)
N(1)–Ag(1)–O(2)#1 85.71(5)
N(1)#2–Ag(1)–O(1) 115.75(5)
N(1)–Ag(1)–O(1) 64.25(5)
O(2)#1–Ag(1)–O(1) 115.85(5)
Symmetry transformations used to generate equivalent atoms: #1 x  1/2,
y, z + 1/2; #2 x + 2, y + 1, z.
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but quite effective against the fungal species. Whilst
[Ag2(salH)2] and [Ag2(salH)2(NH3)2] also exhibited a toxic-
ity bias towards C. albicans1 the ammonia-containing
adduct was more than twice as potent towards both bacte-
rial species. [Ag(MeNO2imH)2]ClO4 Æ 3H2O and silver sul-
fadiazine displayed similar bacterial and fungal activities.
In relation to bacteria, it is important to note that mor-
phological changes have been reported [22] to occur in
AgNO3-treated S. aureus and E. coli cells. Transformations
included shrinkage of the cytoplasmic membrane, possible
detachment of the membrane from the cell wall and DNA
condensation coupled with a loss of replication. In addition
to these morphological changes, protein conglomeration
also occurred in response to AgNO3 treatment, and it
was postulated that this event was possibly to protect the
cell from DNA damage. Furthermore, it was suggested
that the higher dose of AgNO3 was required to kill Gram
Table 4
Antimicrobial activity
Complex MRSA,
MIC50
(lM)
E. coli,
MIC50
(lM)
C. albicans,
MIC100
(lM)
imH 50 50 50
NO2imH 50 50 50
MeNO2imH 50 50 50
apim 50 50 50
salH2 50 50 50
Ketoconazole 4.7
Silver sulfadiazine 19.6 14.0 3.5
AgNO3 36.8 35.3 1.8
AgClO4 Æ H2O 43.4 48.2 1.4
[Ag2(imH)4](salH)2 10.5 10.5 0.1
[Ag(MeNO2imH)2]ClO4 Æ 3H2O 15.5 15.5 4.8
[Ag(apim)]ClO4 30.1 30.1 1.8
[Ag(NO2im)] 45.5 54.6 2.8
[Ag2(salH)2] 40.8 42.8 0.6
[Ag2(salH)2(NH3)2] 17.2 19.1 0.6
[Ag6(imH)12](ClO4)6 50 50 0.3
1 In the current work, [Ag2(salH)2] and [Ag2(NH3)2(salH)2] are equally
effective against C. albicans in minimal media. However, in RPMI media
[Ag2(NH3)2(salH)2] displays approximately 10-fold superior activity than
[Ag2(salH)2] (see Ref. [17]).
Fig. 6. Section of the structure of polymeric Ag(apim)]ClO4.
Fig. 7. Alignment of polymer chains in the structure of [Ag(apim)]ClO4.
Table 3
Selected bond lengths (A˚) and angles () for [Ag(apim)]ClO4
Ag(1)–N(1) 2.1004(17)
Ag(1)–N(3)#1 2.1374(17)
Ag(1)–O(11) 2.9269(18)
Ag(1)–O(14)#1 3.1368(19)
N(3)–Ag(1)#2 2.1374(17)
N(1)–Ag(1)–N(3)#1 173.56(6)
N(1)–Ag(1)–O(11) 97.40(6)
N(3)#1–Ag(1)–O(11) 83.79(6)
N(1)–Ag(1)–O(14)#1 87.05(6)
N(3)#1–Ag(1)–O(14)#1 92.16(5)
O(11)–Ag(1)–O(14)#1 174.47(5)
Symmetry transformations used to generate equivalent atoms: #1 x,
y + 1/2, z + 1/2; #2 x, y  1/2, z + 1/2.
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positive (S. aureus) than Gram negative (E. coli) cells
reflected the fact that the cell wall of the latter species
was considerably thinner. In contrast, under the experi-
mental conditions in which the present study was con-
ducted, neither the Ag(I) complexes or the simple Ag(I)
salts discriminated markedly in their activities towards
Gram positive (MRSA) and Gram negative bacteria
(E. coli).
3. Experimental
Chemicals were purchased from commercial sources
and, unless specified, were used without further purifica-
tion. Literature methods were used to make [Ag2(salH)2]
[23–25], [Ag2(NH3)2(salH)2] [14] and [Ag(im)] [17,19]. Prep-
arations of silver complexes were conducted in the absence
of light and the samples were stored in the dark. Infrared
spectra of solids (in a KBr matrix) were recorded in the
region 4000–400 cm1 on a Nicolet FT-IR Impact 400D
infrared spectrometer. Microanalytical data were provided
by the Microanalytical Laboratory, National University of
Ireland, Cork, Ireland.
Candida albicans (ATCC 10231, Manasas, VA, USA)
was grown on Sabouraud dextrose agar (SDA) plates at
37 C and maintained at 4 C for short-term storage. Cul-
tures were routinely sub-cultured every 4–6 weeks. Cultures
were grown to the stationary phase (approximately
1 · 108 cells cm3) overnight at 37 C and 200 rpm in mini-
mal medium (2% w/v glucose, 0.5% w/v yeast nitrogen base
(without amino acids or ammonium sulfate), 0.5% w/v
ammonium sulfate), again at 37 C. Solutions of water-
soluble test compounds were prepared by dissolving the
compound (0.02 g) in distilled water (10 cm3) to yield a stock
solution with a concentration of 2000 lg cm3. Complexes
which were insoluble in both water and DMSO were made
up (with vigorous agitation) as suspensions in water to give
stock suspensions of 2000 lg cm3. Complexes which were
insoluble in water, but soluble in DMSO, were dissolved
(0.02 g) inDMSO (1 cm3) and added to water (9 cm3) to give
a stock solution (concentration 2000 lg cm3). Doubling
dilutions of these various stock solutions (or suspensions)
were made to yield a series of test solutions (or suspensions).
It is important to note that, in general, the antimicrobial
activity of the Ag-containing solutions/suspensions deterio-
rated markedly even upon storage at 4 C for short periods.
Thus, fresh solutions/suspensions were prepared immedi-
ately prior to testing. Minimum inhibitory concentrations
(MIC100 values, minimum concentration required to inhibit
100% of cell growth) were then determined using the broth
microdilution method [26,27].
Escherichia coli was obtained from the Clinical Microbi-
ology Laboratory, St. Jamess Hospital, Dublin, Ireland,
and MRSA from Microbiologics, North St. Cloud Mn,
USA. Bacteria were maintained on Nutrient Agar plates
at 4 C and cultured in liquid broth (LB) when required.
LB was used for the antibacterial testing. LB (13 g) was dis-
solved in water (1 L) in a Duran bottle, and then dispensed
into 250 cm3 conical flasks, autoclaved and allowed to cool.
Both E. coli and MRSA were grown in LB at 30 C and
200 rpm to an OD600 of 1.0. A microtiter plate was inocu-
lated with 100 ll of bacterial cells (OD600 = 1.0). Solutions
of silver complexes were prepared by dissolving (or sus-
pending) the complex (0.02 g) in DMSO (0.5 cm3). To this
solution/suspension was added filter-sterilised Millipore
water (9.5 cm3) to produce a stock solution/suspension of
concentration 2000 lg cm3. Stock solution/suspension
(1.0 cm3) was added to nutrient broth media (9 cm3) to
produce a drug solution/suspension of concentration
200 lg cm3 with the concentration of DMSO being
0.5%. This solution/suspension (100 ll) was added to the
microtiter plate. 1:1 serial dilutions were made so as to pro-
duce a test concentration range of 50–0.1 lg cm3. The
plates were incubated at 30 C overnight and OD600 values
were read using an RMX plate reader (USA) to give MIC50
values (minimum concentration required to inhibit 50% of
cell growth). Experiments were performed in triplicate and
the data analysed using MICROSOFT EXCEL.
3.1. [Ag2(imH)4](salH)2
[Ag2(salH)2] (0.37 g, 0.76 mmol) and imidazole (0.23 g,
3.38 mmol) were refluxed in ethanol (15 cm3) for 2.5 h.
The mixture was filtered whilst hot to remove a small
amount of a pale pink solid. The filtrate was concentrated
to dryness to give a white solid product. The solid was
washed with ethanol and allowed to air-dry. Yield: 0.30 g
(52%). To obtain crystals suitable for X-ray structural
analysis the original filtrate was allowed to slowly evapo-
rate to low volume over a period of days. The white com-
plex was only soluble in warm DMSO. Anal. Calc.: C,
40.96; H, 3.44; N, 14.70. Found: C, 40.64; H, 3.30; N,
14.03%. IR: 3419, 1608, 1486, 1377, 1062, 745 cm1.
3.2. [Ag(apim)]ClO4
AgClO4 (0.5 g, 2.2 mmol) was dissolved in ethanol
(20 cm3) and apim (0.69 g, 5.5 mmol) added. The resulting
white suspension was stirred at room temperature for 1 h
and the solvent then decanted off. The solid was washed with
ethanol (3 · 10 cm3) and then dried under vacuum. Yield:
0.58 g (72%). The complex was only very slightly soluble
in DMSO and insoluble in all other solvents. Anal. Calc.:
C, 21.67; H, 3.33; N, 12.64. Found: C, 22.57; H, 3.36; N,
13.04%. IR: 3323, 3110, 2935, 1511, 1111, 1088, 627 cm1.
3.3. [Ag(MeNO2imH)2]ClO4 Æ 3H2O
To a solution of 2-methyl-5-nitroimidazole (0.224 g,
1.76 mmol) in ethanol (20 cm3) was added silver prechlorate
monohydrate (0.215 g, 0.95 mmol) and the reaction mixture
refluxed for 2 h. A small amount of an insoluble white solid
was filtered off and the filtrate concentrated to give the prod-
uct as a white powder. The solid was washed with water and
then with ethanol and then air-dried. Yield: 0.36 g (76%).
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The complex was reasonably stable in light and was spar-
ingly soluble in DMSO and insoluble in all other common
solvents. Anal. Calc.: C, 18.64; H, 3.13; N, 16.30. Found:
C, 18.63, H, 2.27, N, 16.00%. IR: 3162, 3045, 2896, 1711,
1572, 1506, 1380, 1286, 1103, 815, 752, 627 cm1.
3.4. [Ag(MeNO2imH)2]ClO4 Æ H2O
Crystals of composition [Ag(MeNO2imH)2]ClO4 Æ H2O
co-crystallised with some unreacted 2-methyl-5-nitroimi-
dazole when 2-methyl-5-nitroimidazole was reacted with
silver prechlorate monohydrate in a 4:1 molar ratio and
following the procedure outlined for the above preparation
of [Ag(MeNO2imH)2]ClO4 Æ 3H2O.
3.5. [Ag(NO2im)]
[Ag2(salH)2] (0.40 g, 0.82 mmol) and 5-nitroimidazole
(0.28 g, 2.48 mmol) were refluxed in ethanol (20 cm3) for
1 h. The resulting white suspension was filtered whilst hot
and the solid washed with ethanol and then air-dried.
Yield: 0.34 g (95%). The solid was insoluble in all common
solvents. Anal. Calc.: C, 16.38; H, 0.92; N, 19.11. Found:
C, 16.99; H, 0.74; N, 18.65%. IR: 3139, 1498, 1450, 1375,
1239, 1203, 1021, 821, 750, 659 cm1.
3.6. [Ag6(imH)12](ClO4)6
This complex was prepared using a modification of the
literature method [19]. AgClO4 (0.50 g, 2.41 mmol) was dis-
solved in H2O (4 cm
3) and to this was added a solution of
imidazole (0.30 g, 4.41 mmol) in H2O (2 cm
3). To the
resulting white suspension was added, dropwise, perchloric
acid (1.5 cm3) causing the white solid to dissolve. Ethanol
(1.5 cm3) was added and the solution was then concen-
trated to dryness under high vacuum. The majority of the
white solid was redissolved in hot ethanol (20 cm3). The
mixture was filtered and ethyl acetate (25 cm3) added to
the filtrate. Solid NaHCO3 was added portion-wise to the
solution until CO2 evolution ceased. After filtration, the fil-
trate was stirred for 0.5 h and then concentrated to dryness
under high vacuum. The resulting white solid was re-sus-
pended in ethyl acetate (40 cm3) and then filtered off. The
solid was washed with ethyl acetate (3 · 10 cm3) and then
air-dried. Yield: 0.34 g (45%). The complex was soluble in
DMSO but insoluble in H2O and EtOH.
3.7. X-ray crystallography
All data were collected at 150 K on a Bruker SMART
1000 CCD diffractometer using Mo Ka radiation
(k = 0.71073 A˚) and the structures were solved by direct
methods and refined by full-matrix least-squares on F2
using all the data [28]. All non-hydrogen atoms were
refined with anisotropic atomic displacement parameters
and the hydrogen atoms bonded to carbon or amine nitro-
gen atoms were inserted at calculated positions using a rid-
ing model. Hydrogen atoms bonded to either oxygen or
imidazole nitrogen atoms were located from difference
maps and assigned common fixed isotropic displacement
parameters; their coordinates were refined in [Ag2(imH)4]-
(salH)2 but not refined in [Ag(MeNO2imH)2]ClO4 Æ H2O.
Data collection and refinement parameters are summarised
in Table 5.
Table 5
X-ray data for [Ag2(imH)4](salH)2, [Ag(MeNO2imH)2]ClO4 Æ H2O and [Ag(apim)]ClO4
Complex [Ag2(imH)4](salH)2 [Ag(MeNO2imH)2]ClO4 Æ H2O [Ag(apim)]ClO4
Empirical formula C26H26Ag2N8O6 C8H12AgClN6O9 C6H11AgClN3O4
Crystal system triclinic orthorhombic monoclinic
Space group P1 Pnma P21/c
Cell dimensions
a (A˚) 8.6892(7) 11.7774(8) 7.7252(8)
b (A˚) 9.1981(8) 25.1672(18) 12.9936(13)
c (A˚) 9.7645(8) 5.3466(4) 10.4871(10)
a () 89.946(10) 90 90
b () 87.238(1) 90 91.425(2)
c () 62.150(1) 90 90
Volume (A˚3) 689.02(10) 1584.8(2) 1052.35(18)
Z 2 4 4
Absolute coefficient (mm1) 1.478 1.501 2.168
Crystal size (mm3) 0.41 · 0.22 · 0.13 0.23 · 0.20 · 0.13 0.48 · 0.15 · 0.09
Crystal description colourless block colourless hexagonal prism colourless flake
Reflections collected 5946 12508 8709
Independent reflections (Rint) 3113 (0.0104) 1961 (0.0227) 2431 (0.0161)
Completeness (h = 25) (%) 99.4 100.0 100.0
Absorption correction multi-scan multi-scan multi-scan
Data/restraints/parameters 3113/0/199 1961/0/122 2431/0/136
Goodness-of-fit on F2 1.063 1.026 1.067
Final R1, wR2 [I > 2r(I)] 0.0193, 0.0474 0.0218, 0.0475 0.0191, 0.0427
R1, wR2 (all data) 0.0217, 0.0484 0.0336, 0.0519 0.0232, 0.0441
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4. Supplementary data
X-ray supplementary data for [Ag2(imH)4](salH)2,
[Ag(MeNO2imH)2]ClO4 Æ 2H2O and [Ag(apim)]ClO4 are
available from the Cambridge Crystallographic Data Cen-
tre, 12 Union Road, Cambridge CB2 1EZ, England,
www.ccdc.cam.ac.uk/conts/retrieving.html (fax: +44 1223
336033 or e-mail: deposit@ccdc.cam.ac.uk), quoting the
deposition numbers CCDC 272997, CCDC 272998 and
CCDC 281737, respectively.
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